For plasma GFAP, three group comparisons survived FDR correction: levels were lower in MCI Aβ− compared to MCI Aβ+ and AD, and also lower in the “Other dementias” group compared to MCI Aβ+ and AD. Here, GFAP is linked to Alzheimer disease.